Then, the results of CCK-8 and EdU assays demonstrated that OSBPL5 overexpression counteracted LMCD1-AS1 depletion-induced inhibition in NSCLC cell viability and proliferation (Fig. 5B, C, Additional file 1: Figs. S2B-C, S3C-D). This evidence concerns the gene OSBPL5 and non-small cell lung carcinoma.